Skip to main content

Table 4 Univariate and multivariate analyses predicting LNM using preoperative values

From: Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: a case control study

Variable

Univariate

Multivariate

OR (95 % CI)

p-value

OR (95 % CI)

p-value

Gender

Male

1

0.118

  
 

Female

1.46 (0.91–2.34)

   

Agea

 

0.98 (0.96–0.99)

0.025

0.98 (0.96–0.99)

0.017

BMIa

 

1.00 (0.93–1.08)

0.977

  

Gross type

0-I, IIa

1

0.585

  
 

IIb

0.70 (0.35–1.39)

0.304

  
 

IIc, III

0.86 (0.50–1.45)

0.563

  

Histology

Pap, WD, MD

1

0.515

  
 

PD, Muc

1.36 (0.76–2.43)

0.300

  
 

Sig

1.00 (0.57–1.76)

0.991

  

Ulcer

Negative

1

0.037

1

0.037

 

Positive

2.21 (1.05–4.67)

 

2.25 (1.05–4.81)

 

Location

Upper third

1

0.893

  
 

Lower or middle third

1.05 (0.54–2.09)

   

Tumor sizea

 

1.04 (1.01–1.07)

0.010

1.04 (1.01–1.07)

0.009

NLRa

 

1.08 (0.95–1.22)

0.228

  

Tumor detectability in CT scan

Undetectable

1

0.355

  

Detectable

1.30 (0.75–2.26)

   

Presence of LMN in CT scan

Unsuspected

1

0.001

1

0.002

Suspected

3.92 (1.80–8.55)

 

3.57 (1.62–7.88)

 
  1. aAnalyses were performed using continuous values
  2. LNM lymph node metastasis, OR odds ratio, CI confidence interval, BMI body-mass index, Pap papillary adenocarcinoma, WD well differentiated adenocarcinoma, MD moderately differentiated adenocarcinoma, Muc mucinous adenocarcinoma, PD poorly differentiated adenocarcinoma, Sig signet cell ring carcinoma, CLS carcinoma with lymphoid stroma, NLR neutrophil-lymphocyte ratio, CT computed tomography